Malaysian Genomics Resource Centre to Offer Pioneering Holistic Renal Care via New Venture

Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the Group is acquiring a 51% stake...

Novotech Receives CRO Leadership Award for Exceeding Customer Expectations

Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, was awarded a prestigious Clinical Leader and...
SinoMab

The Mechanism of Action of SinoMab’s Flagship Product SM03 is Successfully Published in the...

SinoMab BioScience Limited (SinoMab or the Company, together with its subsidiaries, the Group, HKG 3681), a Hong Kong-listed biopharmaceutical company dedicated to the research,...
EC Healthcare

EC Healthcare Signs Inaugural Dual-Tranche Sustainability-Linked Facility, The First-of-its-Kind in Hong Kong Healthcare Industry

EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, HKG: 2138), the largest non-hospital medical group in Hong...
SinoMab

SinoMab Dosed First Healthy Subject in Phase I Clinical Trial of SM17 in the...

SinoMab BioScience Limited (SinoMab or the Company, together with its subsidiaries, the Group, HKG: 3681), a Hong Kong-based biopharmaceutical company dedicated to the research,...

SINGAPORE ANNUAL MEETING: DIA and CoRE Gathering Key Healthcare Experts in Neutral Forum to...

The COVID-19 pandemic has ushered an increased speed of healthcare innovations with the hope of effectively managing this public health threat. This meeting offers...

Amazfit to Launch Bip 3 Series of Smartwatches in Malaysia from 15 June

Amazfit, a premium smart wearable hardware brand owned by Zepp Health Corporation, is going Big with Bip in the latest launch of smartwatches catered...

Novotech’s APAC and USA Leadership Teams at BIO 2022

Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, will have key executives from APAC and...

Malaysian Genomics Resource Centre Berhad Gets Affected Issuer Status Uplifted

Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce that it is uplifted from being...
SinoMab

SinoMab Announces IND APPLICATION FOR SN1011 ACCEPTED BY NMPA CDE

Continuously expanding the scope of potential indications for SN1011 SinoMab BioScience Limited (SinoMab or the Company, together with its subsidiaries, the Group, HKG: 3681), a...

Hua Medicine Announces Dorzagliatin can Restore Glucose Sensitivity and Early Phase Insulin Secretion in...

Hua Medicine (the Company, HKG: 2552) today announces that several clinical findings were presented on its global first-in-class drug, glucokinase activator (GKA) dorzagliatin, at...

Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China

Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, is sponsoring the Endpoints ASCO22 "Accelerating clinical...

Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR...

 Boehringer Ingelheim gains exclusive global rights to a panel of cancer-specific antibodies to enable the development of targeted cancer therapies These engineered antibodies...

Novotech Sponsors Pre-ASCO China Summit Expert Panels on Early Phase Oncology Trials and Regulatory...

Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, has sponsored expert panels at the Pre-ASCO...

Connected Transactions Involving Subscription by Vivo Suzhou Fund and Centerlab for TOT BIOPHARM Shares

On June 1, 2022, TOT BIOPHARM (Stock code: 1875. HK) announced that the company entered into a Share Subscription Agreement with VIVO Suzhou Fund...

Azelis inaugurates state-of-the-art Regional Innovation Center for Food & Nutrition in Singapore

Azelis, a leading innovation service provider in the specialty chemicals and food ingredients industry, announces the opening of its Regional Innovation Center (RIC) for...

Malaysian Genomics Resource Centre Berhad Posts 212% Increase in Revenue for 3Q FY2022

9-month revenue up nearly 12-fold to RM22.03 million Profit supported by higher margin immunotherapy and cell therapies Malaysian Genomics Resource Centre Berhad, a leading...

Launch of World-first Expert Bone Health Resource

An osteoporotic fracture occurs every three seconds worldwide.(1) More than 50 per cent of the world's hip fractures are expected to occur in the Asia...

Straumann Malaysia, part of The Straumann Group, a Leading Implantology Company, Intends to Provide...

Straumann Group Sdn. Bhd, the Malaysian subsidiary of Straumann Group, global leader in implantology and aesthetic-dentistry, (Straumann Malaysia) intends to provide 3,000 dental implant...

Hua Medicine Published Two Peer-Reviewed Papers in Nature Medicine, an International Top Medical Journal,...

Hua Medicine (the Company, HKG: 2552) today announces that two peer-reviewed papers on Phase III clinical trial results of dorzagliatin, a glucokinase activator (GKA)...